Research has been at the heart of NETRF’s mission for 20 years—and patients are the
reason that work matters. Every study we fund is designed to move the field forward
and improve how people with neuroendocrine cancer live, feel, and are treated.
In this special episode of NETWise, we’re bringing the 2025 NETRF Neuroendocrine
Cancer Research Symposium directly to the patient and caregiver community. You’ll
hear from leading researchers and clinicians as they explain:

  • What’s changed in neuroendocrine cancer research over the past year
  • How new discoveries impact diagnosis, treatment, and everyday patient care
  • Why NETRF’s 20 years of progress is shaping the future of NETs
  • Where the field is headed next—scientifically and clinically

Whether you’re a patient, caregiver, clinician, or advocate, this Year-in-Review episode
offers clear, accessible insights into the breakthroughs driving NET research forward.
Please like, share, and subscribe. Your engagement helps us reach more patients and
caregivers seeking reliable neuroendocrine cancer information—and supports
NETRF’s mission to expand research, awareness, and hope across the NET
community.

NET specialists included in this episode

Use our episode infographics to get a visual picture of some of the things we have discussed.

Po-Hien Ear, PhD
Assistant Professor of Surgery (Surgical Oncology & Endocrine Surgery), University of Iowa Carver College of Medicine

Martyn Caplin, MD, PhD, FRCP
Professor of Gastroenterology & Tumour Neuroendocrinology, Royal Free Hospital & University College London (UCL)

Carl Gay, MD, PhD
Assistant Professor, Department of Thoracic/Head & Neck Medical Oncology
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Pamela Kunz, MD, Keynote Speaker

Pamela L. Kunz, MD
Director, Center for Gastrointestinal Cancers, Smilow Cancer Hospital & Yale Cancer Center
Chief, GI Medical Oncology, Yale School of Medicine

Neil Renwick, MD, PhD, FRCPC
Assistant Professor, Department of Pathology & Molecular Medicine, Queen’s University
(SEAMO New Clinician-Scientist Program)

Nancy Joseph, MD, PhD
Professor of Surgical Pathology, University of California, San Francisco (UCSF)

Anassuya Ramachandran, PhD
Research Fellow at The University of Auckland

Thank you to NETRF staff members Elyse Gellerman and Anna Greene, PhD, and NETRF Board Members Josh Mailman, Todd Gillman, and Suzie Ludlow for their contributions to this episode.

A special thank you to Jake Dawson, Taylor Dawson and Nancy Lewis for sharing their neuroendocrine cancer journeys.

Click here to download a transcript of this episode.